Toll-like receptor 3 plays a central role in cardiac dysfunction during polymicrobial sepsis

Ming Gao1, Tuanzhu Ha, Xia Zhang

  • 1Department of Surgery, Internal Medicine, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, TN, USA.

Insights

Toll-like receptor 3 (TLR3) exacerbates cardiac dysfunction and mortality in polymicrobial sepsis. Blocking TLR3 activity protected mice from sepsis-induced heart damage and improved survival rates, suggesting TLR3 as a therapeutic target.

Area of Science:

  • Immunology
  • Cardiovascular Biology
  • Sepsis Pathophysiology

Background:

  • Myocardial dysfunction is a critical factor in septic shock mortality.
  • Toll-like receptors (TLRs) are key mediators in sepsis pathogenesis.
  • TLR3 recognizes double-stranded RNA and is implicated in inflammatory responses.

Purpose of the Study:

  • To investigate the specific role of Toll-like receptor 3 (TLR3) in the development of cardiac dysfunction during polymicrobial sepsis.
  • To assess the impact of TLR3 deficiency on cardiac function, survival, and inflammatory signaling pathways in a sepsis model.

Main Methods:

  • A controlled animal study using male C57BL/6 wild-type and Toll-like receptor 3 knockout (TLR3-/-) mice.
  • Polymicrobial sepsis was induced via cecal ligation and puncture (CLP).
  • Cardiac function was evaluated using echocardiography; survival and myocardial inflammatory markers were assessed.

Main Results:

  • Cecal ligation and puncture (CLP) induced significant cardiac dysfunction in wild-type mice.
  • TLR3 knockout mice maintained cardiac function and exhibited significantly improved survival rates compared to wild-type controls.
  • TLR3 deficiency attenuated cardiac myocyte apoptosis, reduced inflammatory mediator expression, and inhibited TLR4-mediated signaling pathways.

Conclusions:

  • Toll-like receptor 3 (TLR3) plays a detrimental role in sepsis-induced cardiac dysfunction.
  • Targeting TLR3 activity presents a potential therapeutic strategy for preventing cardiac complications in sepsis.
Abstract

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Acute Inflammation III: Local and Systemic Effects01:25

Acute Inflammation III: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...